Skip to main content
. 2021 Aug 30;13(17):4385. doi: 10.3390/cancers13174385

Table 2.

Familial risk for index persons whose parents or siblings were diagnosed with concordant cancer.

Cancer Site Only Parent Diagnosed with Concordant Cancer Only Sibling Diagnosed with Concordant Cancer
O SIR 95% CI O SIR 95% CI
Lip 73 1.78 1.39 2.24 46 2.44 1.79 3.26
Salivary gland 3 1.80 0.34 5.34
Pharynx 15 1.66 0.93 2.75 30 3.88 2.62 5.55
Esophagus 43 2.37 1.71 3.19 30 2.91 1.96 4.16
Stomach * 307 1.66 1.48 1.85 94 2.74 2.22 3.36
Small intestine 31 5.37 3.65 7.63 21 6.11 3.78 9.36
Colorectum 4981 1.66 1.62 1.71 2252 1.76 1.69 1.84
          Colon 2249 1.79 1.71 1.86 1060 1.96 1.84 2.08
          Rectum 696 1.61 1.49 1.73 341 1.69 1.52 1.88
Liver, primary 56 2.30 1.73 2.98 28 2.65 1.76 3.84
Pancreas 320 1.99 1.78 2.22 135 2.17 1.82 2.57
Lung * 2247 1.86 1.79 1.94 1875 2.50 2.39 2.62
Breast 9154 1.74 1.70 1.77 6573 1.73 1.69 1.77
Cervix 155 1.51 1.28 1.76 68 1.58 1.23 2.01
Endometrium 511 1.94 1.78 2.12 288 1.82 1.61 2.04
Ovary 319 2.32 2.08 2.59 162 2.31 1.97 2.70
Prostate * 11,791 2.05 2.01 2.09 9897 2.38 2.33 2.43
Testis 51 4.56 3.39 5.99 107 5.56 4.55 6.72
Kidney 211 1.77 1.54 2.03 108 2.38 1.95 2.87
Bladder 835 1.76 1.64 1.88 459 1.94 1.77 2.12
Melanoma 1360 2.37 2.24 2.49 1260 2.45 2.32 2.59
Skin 991 1.98 1.86 2.11 426 1.89 1.72 2.08
Eye 8 3.30 1.41 6.53 2 1.42 0.13 5.24
Nervous system 443 1.49 1.36 1.64 320 1.64 1.47 1.83
Thyroid gland, adenocarcinoma 71 3.78 2.95 4.77 65 4.98 3.84 6.35
Endocrine glands 201 2.03 1.76 2.34 124 2.00 1.67 2.39
Bone 5 6.11 1.93 14.36 4 8.23 2.14 21.29
Connective tissue 22 1.76 1.10 2.67 10 1.61 0.77 2.97
Hodgkin disease * 23 2.87 1.81 4.31 34 6.77 4.69 9.47
Non-Hodgkin lymphoma 443 1.66 1.51 1.82 294 1.80 1.60 2.02
Myeloma 96 1.92 1.56 2.35 44 2.00 1.45 2.69
Leukemia 409 1.83 1.66 2.02 217 1.97 1.72 2.26
All above * 38,120 1.86 1.84 1.88 26,374 2.07 2.04 2.09

O = Observed; SIR = Standardized incidence ratio; CI = Confidence intervals. *: SIRs between cases with parental and sibling probands were significant (non-overlapping 95%CIs).